Biomaterials liability reform action urged by AMA as bill stalls in Congress.
This article was originally published in The Gray Sheet
Executive Summary
BIOMATERIALS LIABILITY REFORM CONGRESSIONAL ACTION URGED BY AMA in a resolution passed at the group's House of Delegates meeting held June 18-22 in Chicago. The American Medical Association will urge Congress "to expedite legislation that has been passed...to afford the protection of the law to manufacturers of critically important medical materials and devices and the professionals who use them."You may also be interested in...
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Novartis Targets Ten Indications For Cosentyx
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Zydus Cadila Strides Ahead With NASH Filing In India
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: